News

HealtNewest updates you on health,nutrition, lifestyle, fitness, diet, cancer, medicine, disease, wound care, beauty products, and other healthy living topics.

The FDA granted accelerated approval to tisotumab vedotin-tftv (Tivdak), a first-in-class drug, for the treatment of patients with recurrent or metastatic cervical cancer, drugmakers Seagen and Genmab announced. Tisotumab vedotin, a tissue factor-directed antibody and microtubule inhibitor conjugate, is indicated for women whose disease progressed on or following chemotherapy. Approval was based on findings from
0 Comments
The COVID-19 pandemic is far from over, but the official death toll has already surpassed the estimated fatalities from the 1918 influenza outbreak, making it the deadliest health crisis in recent American history.  Influenza Outbreak vs. COVID-19 Pandemic Johns Hopkins University reported on its website Monday that the deaths in the country due to COVID-19
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID-19 has now killed at least 675,000 Americans, a death toll that has surpassed the estimates of the number of Americans who died during the 1918 influenza pandemic, according to data collected by Johns Hopkins University. Although the raw numbers match,
0 Comments
MONTPELIER, Vt. (AP) — The Vermont State Police has its first director of mental health programs to help coordinate and oversee the delivery of mental health services to people who come into contact with state police, officials said. Mourning Fox, who was deputy commissioner of the Vermont Department of Mental Health for the last four
0 Comments
Adjuvant pembrolizumab (Keytruda) following complete melanoma resection could soon move to an earlier stage in the management of high-risk disease, suggest results from KEYNOTE 716. However, the results raise many questions, says an expert invited to discuss the new data. Adjuvant pembrolizumab is already approved in the USA for use in patients with melanoma with
0 Comments
A majority of patients with Parkinson disease (PD) experiencing “off” episodes  successfully tolerated titration to an effective and tolerable dose of sublingual apomorphine film (SL-apo; Kynmobi, Sunovion Pharmaceuticals) without the use of antiemetic medication, new research shows. “The bottom line was that the majority of patients did not have dose-limiting nausea or vomiting,” co-investigator William
0 Comments
The visual disorder amblyopia, also known as “lazy eye,” can be impossible to treat once children reach adolescence. Now, a new Israel study links cases in older teenagers to higher rates of poverty, below-average cognitive scores, immigrant status, and obesity.   The research suggests that poorer children need more visual screening, especially in the United States
0 Comments
Details of what works, and what doesn’t, in triple-negative breast cancer (TNBC) come from long-term follow-up of the phase 3 randomized BrighTNess trial. The initial improvement that was seen in pathologic complete response (pCR) rates with the addition of carboplatin to paclitaxel and standard neoadjuvant chemotherapy translated into improved event-free survival (EFS) rates in patients
0 Comments
On September 1, Texas Senate Bill 8 went into effect. While the law’s stated goal is to severely limit a woman’s constitutional right to an abortion in Texas, it also designates private citizens to sue not just abortion providers, but anyone “aiding and abetting” a woman seeking to obtain an abortion after 6 weeks of
0 Comments
Latest figures have shown that obesity cases are on the rise amid the COVID-19 pandemic. Did the global health crisis play a role in the surge in obesity cases in sixteen states?  The Latest Figures The Centers for Disease Control and Prevention (CDC) reported Wednesday that there has been an increase in the number of
0 Comments
New evidence suggesting that the benefit of ticagrelor outweighs the risk when added to aspirin for 30 days after a mild-to-moderate ischemic stroke or high-risk transient ischemic attack (TIA) has been reported from a secondary analysis of the THALES trial. The new analysis was presented at the recent European Stroke Organisation Conference (ESOC) and published
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The largest nonprofit health system in Texas has secured a temporary restraining order against cardiologist Peter A. McCullough, MD, MPH, a COVID-19 vaccine skeptic who allegedly continued to claim an affiliation with Baylor Scott & White Health months after he entered
0 Comments